← Back to Companies

Alexion Pharmaceuticals, Inc.


Alexion Pharmaceuticals, Inc., headquartered in Cheshire, CT, is a global biopharmaceutical company. Alexion scientists are among the first in the world to unlock the therapeutic potential of a group of proteins that play an important role in the body's immune response and can destroy healthy tissue in certain patients. Alexion is working urgently to investigate additional biopharmaceuticals as treatments for patients with other rare and severe diseases, including cancer.

New Haven, CT USA
Primary Address:
100 College Street
New Haven, CT 6510
Parent Company:
Alexion Pharmaceuticals, Inc.

Employees (34)

NameTitleEmailPhone NumberSocial Media
A***** A********Senior Specialist, Marketing Operations - US Neurologya**************[email protected]
L**** B******Director, Payer Marketing - USl***********[email protected]
S****** B*********Global Marketing Lead, Nephrology - Therapeutic Areas****************[email protected]
D**** B******Chairmanb******[email protected]
K******** B****Director, Brand Marketing - Healthcare Professionalsk*************[email protected]
J****** B****Associate Director, Patient Services - Neurology Strategyj***********[email protected]
O***** C****Senior Specialist, Global Marketing Operations - Promotional Review Committeeo**********[email protected]
K*** C*****Director, Marketing - US aHUSk********[email protected]
K**** C*****Director, Marketing - US Metabolicsk**********[email protected]
B******* C******Vice President, Global Marketingb**************[email protected]
A*** C********Director, Consumer Marketinga************[email protected]
C******** D******Executive Director & Head, Marketing - Metabolics & TLL & Interim Launch Lead - US CAEL101c***************[email protected]
(475) 230-****
R***** E******Senior Manager, Global Marketing Operationsr************[email protected]
I****** F********Chief Compliance Officer & Executive Vice Presidentf********[email protected]
J*** G*******Head, Marketing - US Neurologyj***********[email protected]
E******** G****Associate Director, Patient Marketing - US Metabolicse*************[email protected]
T**** G********Manager, Patient Marketing - aHUS USt*************[email protected]
L***** H******Chief Executive Officerl************[email protected]
G*** K******Senior Director, Marketing - Factor Xa Reversalg**********[email protected]
M**** M*****Digital Business Partnerm**********[email protected]
M******** N********Associate Director, Payer Marketing & Value Marketing Lead - USm****************[email protected]
C**** M*******Director, Post Marketing Processing & Expedited Safety Reporting - GDS Operationsc************[email protected]
K**** M*****Director, US Marketing - NMOSD
D***** P********Head, Marketing - US NMOSDd**************[email protected]
B***** P******Marketing Manager - US Commercialb************[email protected]
L**** P*****Director, Marketing - US HCPl**********[email protected]
B** P******Global Marketing Lead - Hematology Therapeutic Areab*********[email protected]
M*** R*******Patient Marketing Team Lead - US Complement BUm***********[email protected]
L**** R***Senior Manager, Patient Services Marketingl********[email protected]
M****** S********Senior Marketing Specialist - US Neurologym***************[email protected]
E******** S*******Launch Lead, Metabolics Marketing - US Wilsone****************[email protected]
A**** S******Director & Marketing Lead - US HCP & Metabolicsa***********[email protected]
S**** S********Senior Director & Head, Global Marketing - Metabolic Disorderss*************[email protected]
J***** T***Marketing Directorj*********[email protected]
Last Updated on Jan 30, 2020